Magnificent Marvel Supersale
 
 

Special Offers see all

Enter to WIN a $100 Credit

Subscribe to PowellsBooks.news
for a chance to win.
Privacy Policy

Visit our stores


    Recently Viewed clear list


    The Powell's Playlist | March 13, 2015

    Kent Russell: IMG Kent Russell's Playlist for I Am Sorry to Think I Have Raised a Timid Son



    I don't listen to music while I write. Frankly, I don't see how anyone can. Since all style is rhythm, and since I cannot write anything that's as... Continue »

    spacer

This item may be
out of stock.

Click on the button below to search for this title in other formats.


Check for Availability
Add to Wishlist

Cell Game, The

Cell Game, The Cover

 

Synopses & Reviews

Publisher Comments:

It began with a promising cancer drug, the brainchild of a gifted researcher, and grew into an insider trading scandal that ensnared one of America's most successful women. The story of ImClone Systems and its "miracle" cancer drug, Erbitux, is the quintessential business saga of the late 1990s. It's the story of big money and cutting-edgescience, celebrity, greed, and slipshod business practices; the story of biotech hype and hope and every kind of excess.

At the center of it all stands a single, enigmatic figure named Sam Waksal. A brilliant, mercurial, and desperate-to-be-liked entrepreneur, Waksal was addicted to the trappings of wealth and fame that accrued to a darling of the stock market and the overheated atmosphere of biotech IPOs. At the height of his stardom, Waksal hobnobbed with Martha Stewart in New York and Carl Icahn in the Hamptons, hosted parties at his fabulous art-filled loft, and was a fixture in the gossip columns. He promised that Erbitux would "change oncology," and would soon be making $1 billion a year.

But as Waksal partied late into the night, desperate cancer patients languished, waiting for his drug to come to market. When the FDA withheld approval of Erbitux, the charming scientist who had always stayed just one step ahead of bankruptcy panicked and desperately tried to cash in his stock before the bad news hit Wall Street.

Waksal is now in jail, the first of the Enron-era white-collar criminals to be sentenced. Yet his cancer drug has proved more durable than his evanescent profits. Erbitux remains promising, the leading example of a new way to fight cancer, and patients and investors hope it will be available soon.

Synopsis:

Beneath the ImClone headlines that shout "Martha Stewart" and "Insider Trading" lies a heartbreaking story of desperate cancer patients waiting in vain for a "miracle" drug that would keep them alive. 8-page photo insert.

About the Author

Alex Prud'homme is a writer living in Brooklyn, New York. His work has appeared in Vanity Fair, The New Yorker, the New York Times, Time, and People.

Product Details

ISBN:
9780061371837
Publisher:
HarperCollins e-books
Subject:
Business & Economics : Business Ethics
Author:
Prud'homme, Alex
Publication Date:
June 2007
Binding:
eBooks
Language:
English
Pages:
432

Related Subjects

Cell Game, The
0 stars - 0 reviews
$ In Stock
Product details 432 pages HarperCollins e-books - English 9780061371837 Reviews:
"Synopsis" by , Beneath the ImClone headlines that shout "Martha Stewart" and "Insider Trading" lies a heartbreaking story of desperate cancer patients waiting in vain for a "miracle" drug that would keep them alive. 8-page photo insert.
spacer
spacer
  • back to top

FOLLOW US ON...

     
Powell's City of Books is an independent bookstore in Portland, Oregon, that fills a whole city block with more than a million new, used, and out of print books. Shop those shelves — plus literally millions more books, DVDs, and gifts — here at Powells.com.